BioXclan specialises in funding outstanding biotechnology and synthetic biology companies from pre-seed through to series A stages. Our team understands that molecular biology research doesn't happen overnight and we're passionate about bringing high quality, patient investment, to companies with exciting and disruptive technologies. Our focus is on ideas that have a significant impact on our environment or our health. Ultimately we want to help solve some of the biggest problems our world is facing: global warming, increasing antibiotic resistance, potential food shortages, pollution of the food chain, clean energy, personal health management and better clinical outcomes for disease.
Korea is a fast growing economy known the world over for its high tech products. In addition to providing companies with funding we want to open up the Korean market to businesses looking to expand from Europe and the US into the Asian markets. We provide a unique combination of technical expertise, high quality network contacts and access to manufacturing facilities.
Korea is also hungry for great biotech companies to invest in with the KOSDAQ (the Korean equivalent of the NASDAQ) currently having the highest P/E valuations for biotech companies worldwide. We can also help companies looking to list on the KOSDAQ.